Full-Time

Histotechnologist

Tempus

Tempus

1,001-5,000 employees

AI-driven precision medicine through clinical and molecular data analysis

Data & Analytics
AI & Machine Learning

Junior, Mid, Senior

Durham, NC, USA

Required Skills
Communications
Requirements
  • HT or HTL Certification preferred
  • Associates or Bachelor's Degree
  • Familiarity with Leica equipment, manual microtomes, both Leica and Roche automated IHC staining instruments
  • Laboratory
  • Knowledge of CAP regulations
  • Experience with pathology laboratory SOPs and protocols
  • Comfort with laboratory safety and training
  • Demonstrates problem solving skills in the laboratory
  • Good communication and organization skills
Responsibilities
  • Preparation of both unstained and routine hematoxylin and eosin stained slides from formalin fixed paraffin embedded tissue blocks
  • Maintain laboratory equipment and record maintenance regularly
  • Approach work with safety and diligence and follow safety requirements of the laboratory
  • Perform routine workflows without specific guidance
  • Reliably produce quality finished product
  • Assist in the development of standard operating procedures for new instruments and products
  • Collaborate with other members of the Tempus Labs team
  • Ulitize microtome, water bath, automated stainer, automated coverslipper , tissue processors, and embedding centers
  • Collaborate with in-house pathologists for slide quality review
  • Ability to cut frozen sections using a cryostat
  • Track work completed using a custom Laboratory Information Management System (LIMS)
  • Work collaboratively with other members of the Histology team to accomplish daily cutting and staining deadlines

Tempus Labs, Inc. is a leader in precision medicine, leveraging artificial intelligence to analyze vast clinical and molecular data, enabling physicians to deliver personalized, data-driven care. The company's advanced machine learning platform and unique solution sets facilitate the discovery, development, and delivery of optimized therapeutic options for patients. With a focus on extensive molecular profiling, Tempus has developed a robust pan-cancer tumor organoid platform and validated a liquid biopsy assay, demonstrating their commitment to transforming personalized patient care and their position at the forefront of the healthcare industry.

Company Stage

Series G

Total Funding

$1.3B

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

8%

1 year growth

32%

2 year growth

52%
INACTIVE